Aicore Life Sciences Netherlands
Treatment of estrogen deficiency symptoms in postmenopausal women, if menopause occurred more than one year ago.
Prevention of osteoporosis in postmenopausal women at high risk of fractures, if they are intolerant to or contraindicated for other medicinal products approved for the treatment of osteoporosis.
Composition:
Active ingredient: tibolone.
Each tablet contains 2.5 mg of tibolone. Manufacturer:
Cenexi, France.
Manufacturer’s location and address:
17 Rue de Pontoise, OSNI, 95520, France.
Applicant:
Aicore Life Sciences B.V., Netherlands.
Applicant’s location:
Boxbergerweg 119, 7431 PM Diepenveen, Netherlands.
